Commercial Credit Report for Harvard Scientific Corp.

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Harvard Scientific Corp. is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Harvard Scientific Corp.
1325 Automotive Way #125
	Reno, NV 89502 United States

This company is no longer actively traded on any major stock exchange.

Business Summary

Harvard Scientific Corp. is a development-stage biopharmaceutical company with two lines of business. The Company utilizes medically researched and developed drug substances, determines the ability of these substances to be encapsulated in liposomes and determines the potential market for such products. Through its acquired group of entertainment businesses, the Company intends to conduct and conclude, either on its own or with the assistance of an industry partner, all clinical testing necessary for regulatory approval of such products from the United States Food and Drug Administration, or similar regulatory agencies in foreign countries, in order to initiate marketing and establish distribution channels for its products. During 2001, the Company plans to devote its resources to the entertainment businesses.

(Source: 10KSB)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2000	12/31/2000	-	Yes	Yes	-	-

Industries

SIC Code	Description
2833	Medicinal chemicals and botanical products

Business Names

Business Name
Harvard Scientific Corp.
VGENQ

General Information

Outstanding Shares:	29,325,712	(As of 4/12/2001)
Shareholders:	302
Stock Exchange:	OTC
Federal Tax Id:	880226455

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN